ACE inhibitor and angiotensin type I receptor antagonist in combination reduce renal damage in obese Zucker rats

This publication has 65 references indexed in Scilit:

• ACE Inhibition Versus Angiotensin Type 1 Receptor Antagonism
  Hypertension, 2002
• Renal damage associated with proteinuria
  Kidney International, 2002
• The Role of the Angiotensin System in Cardiac Glucose Homeostasis
  Drugs, 2002
• EFFECTS OF LOSARTAN AND BENAZEPRILON ABNORMAL CIRCADIAN BLOODPRESSURE RHYTHM AND TARGETORGAN DAMAGE IN SHRSP
  Clinical and Experimental Hypertension, 2002
• Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
  The Lancet, 1999
• Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.
  Journal of Clinical Investigation, 1995
• Benazepril
  Drugs, 1991
• The Zucker fatty rat as a genetic model of obesity and hypertension.
  Hypertension, 1989
• Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats
  Kidney International, 1984
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.
  Journal of Histochemistry & Cytochemistry, 1981